Navigation Links
Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
Date:7/14/2009

-AD Cohort (Malone D, et al.)

A retrospective data analysis showed that AD patients appear to have a higher prevalence of certain serious conditions compared to patients without AD. These analyses were comprised of an evaluation of claims data for more than 33 million Americans from a managed care population over the course of eight years. The study authors concluded that the most notable serious conditions were decubitus ulcers (bed sores, 5-fold higher), seizures (4-fold higher), hip fractures, (3-fold higher), depression (3-fold higher), and pneumonia (2-fold higher).

According to Professor Roy Jones, Director, The Research Institute for the Care of Older People, Bath, United Kingdom, these conditions alone can add significant burden to patients and their loved ones, but in combination with AD, they often translate into significant financial cost, poor health outcomes, and higher risk of death. "I regularly see elderly patients who have multiple conditions that increase the complexity of their care, but until now there have been little data available to reflect the significance and increased prevalence of other conditions in people with Alzheimer's disease," Professor Jones said.

Poster #P2-066: Web-Based Application to Estimate and Project the Burden of Alzheimer's Disease and Evaluate the Impact of Potential Interventions (Colantuoni E, et al.)

More than 26 million people worldwide are estimated to have Alzheimer's disease; however, an updated model suggests that global AD prevalence can be expected to increase to over 100 million by 2050. The Web-based application presented in the poster allowed cost estimate calculations on the future burden of AD. The tool was shown to generate projections for a specified population and generate estimates of disease burden, costs, and/or Disability Adjusted Life Years (DALYs), along with the impact of interventions that can reduce ri
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
2. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
3. iCardiac Selected for Multiple Cardiac Safety Studies
4. Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association
5. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
6. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
7. Results From Neurotechs NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
8. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
9. Spectros T-Stat Tissue Oximeter Clinical Studies Presented at PAS (Pediatric Academic Societies) Conference
10. Lilly Set to Unveil More Than 50 Studies at ASCO 2009
11. Avoiding False Positives Key Priority in Cardiac Safety Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Honors from the Rx Club, the Daveys, the GLOBALS, ,and ... ... (PRWEB) December 17, 2009 -- Chicago-based full-service healthcare communications ... advertising and marketing awards programs honoring exceptional creative and interactive ... Club presented G&A with 9 Awards of Excellence for the ...
(Date:12/16/2009)... scientists at the University of East Anglia (UEA) could ... or agricultural waste to generate clean electricity. , Published ... the National Academy of Sciences (PNAS), the researchers ... which some bacteria survive by ,breathing rocks,. , The ... of new microbe-based technologies such as fuel cells, or ...
(Date:12/16/2009)... -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), ... today announced that it will be launching the ... gene-expression profiling using its SmartChip(TM) Real-Time PCR System. ... comprehensive human microRNA panel of 885 microRNAs on ... offers customers the use of its proprietary SmartChip ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
Breaking Biology Technology:Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
... PHILADELPHIA and LYON, France, Jan. 13 ... Penn Jersey Region of American Red Cross ... an agreement concerning the GMP clinical batches ... United States.(Logo: http://www.newscom.com/cgi-bin/prnh/20090113/DC58023LOGO ) , (Logo: ...
... for Thursday, January 15th at 1:00PM PTNEW YORK, Jan. ... ) today announced that Michael S. Weiss, the Company,s ... at the J.P. Morgan 27th Annual Healthcare Conference being ... live on Thursday, January 15th at 1:00pm PT and ...
... Pharmaceuticals, Inc. (Nasdaq: ALSE ), today announced that ... agreement (the "Agreement") with Robert Gipson for the private placement ... a purchase price of $1.00 per share. The financing ... connection with the Agreement, Mr. Gipson agreed to the cancellation ...
Other Biology Technology:ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross 2Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference 2Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 2Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 3Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 4
(Date:12/16/2009)... Society has announced the winners of its student travel ... at the Moscone Convention Center in San Francisco, California, ... are selected based on scientific merit, with priority given ... conference. Each awardee receives a travel grant and ... 20. , The 2010 recipients of the Student Travel ...
(Date:12/16/2009)... get psyched up for contests, but when these rituals ... down before and during events, they could be causing ... for the symptoms of an injury, not the injury ... focuses on musculoskeletal health and sports medicine. "They may ... certain level, but pain occurs for a reason. It ...
(Date:12/16/2009)... 1 iQor, a global provider of business ... InfoWorld 100 Awards Top 100 IT project ... was the first submission for iQor. ,, "We are ... companies," said Vikas Kapoor, president and CEO of iQor. ... allowing us to work faster, smarter and with the ...
Breaking Biology News(10 mins):Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4NSAIDs: Take 'em early and often when competing? Think again 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Studies examine how living conditions impact reproductive health 10141 1Studies examine how living conditions impact reproductive health 10141 2Temps Inc Acquires Medical Concepts Staffing Business From Analysts International Corporation 58423 1Temps Inc Acquires Medical Concepts Staffing Business From Analysts International Corporation 58423 2Heart Patients Benefit From At Home Care Study Finds 58421 1Heart Patients Benefit From At Home Care Study Finds 58421 2
... The December 2008 issue of BioScience includes a ... the Environment, coordinated by Louis J. Guillette, Jr., of the ... in the issue is as follows: , Meeting the ... John P. Incardona, and Matthew L. Rise. , As a ...
... summer for sports, fans. World records tumbled at the ... 200m world records, knocking tenths of a second off ... the last few decades, which made marathon runner Mark ... increase in population could account for these dramatic improvements. ...
... (SRC-2) a master regulator gene called a coactivator fast ... another day without food, they will die. , The severity ... W. O,Malley, chair of molecular and cellular biology at Baylor College ... that appears in the current issue of the journal Science ...
Other Biology News:BioScience tip sheet, December 2008 2100-meter sprint world record could go as low as 9.48 seconds 2Master gene plays key role in blood sugar levels 2
Human Cell Line Slides...
... Each Signet Level 2 Detection System ... avidin-biotin chemical bonding principle and Signets ... provide sensitivity, specificity and reliablility. Signet ... in both manual and automated protocols. ...
... Signet Level 2 Detection System combines ... chemical bonding principle and Signets unique ... sensitivity, specificity and reliablility. Signet reagents ... both manual and automated protocols. ...
XPMC2H Immunogen: XPMC2H (NP_065118, 323 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: